Combination Chemotherapy in Treating Patients With Stage II or Stage III Multiple Myeloma

NCT00006232 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma and Plasma Cell Neoplasm

Interventions

DRUG: dexamethasone
DRUG: doxorubicin hydrochloride
DRUG: idarubicin
DRUG: vincristine sulfate

Sponsor

West of Scotland Lymphoma Group